跳至主要内容
临床试验/NCT01901523
NCT01901523Unknown不适用

Phase II Study of Response of Medical Journal Editorial Boards to Notification of Serious Discrepancies in Published Clinical Trials in Human Patients.

Imperial College London2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
15
试验地点
2
主要终点
Time to correction, retraction, or other notification to the readership of discrepancy

研究概览

简要总结

Clinical research, like all science, is self-correcting, with errors detected by the scientific community and communicated to the publishing journals, which then relay the information (and its resolution) to its readers. If this relaying process fails, science grinds to a halt. In this study we are testing its integrity.

详细描述

This prospective study documents the outcome of notification to journal editorial boards (or equivalent authorities) of factually incorrect or inconsistent claims, in reports they have published.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Report of a clinical trial in humans of treatment of heart disease with bone marrow derived stem cells
  • Report containing discrepancy by reference to same report or another report

排除标准

  • Discrepancy has already been corrected by an erratum

结局指标

主要结局

Time to correction, retraction, or other notification to the readership of discrepancy

时间窗: 12 months

次要结局

  • Time to initial response from journal(0-4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Darrel Francis

Professor of Cardiology

Imperial College London

研究点 (2)

Loading locations...

相似试验